GTHP's cervical cancer scan is approved in EU, Asia, Canada, Mid East
Awaiting FDA approval.
Over 60 million PAP smear tests are taken annually.
GTHP's biophotonic scan is noninvasive, more accurate and produces instant test results.
Superior technology for a huge market at 1/8 the market cap of CHTP.
ive also been looking at gthp, the way they test for cancers seems way more efficient than other methods...however not much has changed with gthp in the past, so i think ill wait and watch for a month or two..
A lot has changed:
They just got approved in the EU recently.
The order from the Turkish Health Ministry will show up in this past Q4 earnings statement.
Meeting with the FDA was held.
New distributors are being signed up.
Esophagal cancer scan is being advanced.